Sabra Health Care REIT, Inc.

The company holds $246.3M in cash, though total debt stands at $2.63B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $155.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 2.4%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $624.8M (2022) to $774.6M (2025), reflecting a 24% increase over the period.

With a beta below 0.7, Sabra Health Care REIT, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Sabra Health Care REIT, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. No single metric tells the full story. Reviewing SBRA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.